MedTrace Logo

Quick Start of Highly Effective Contraception

NCT02076217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2026-04-06

No results posted yet for this study

Summary

This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).

Conditions

  • IUD
  • Contraceptive Implant
  • Contraception
  • Birth Control
  • Emergency Contraception

Interventions

DRUG

Copper T-380 IUD

DRUG

LNG IUD

DEVICE

Contraceptive implant Nexplanon

DRUG

Depo-Provera

Sponsors & Collaborators

Principal Investigators

  • David Turok, MD · University of Utah

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076217 on ClinicalTrials.gov